Estrogen alleviates neuropathic pain induced after spinal cord injury by inhibiting microglia and astrocyte activation
Estrogen alleviates neuropathic pain induced after spinal cord injury by inhibiting microglia and astrocyte activation
复制标题
DOI:
10.1016/j.bbadis.2018.04.006
复制
发表时间:
2018-07-01
影响因子:
6.2
通讯作者:
Yune, Tae Young
中科院分区:
文献类型:
--
作者:
Lee, Jee Youn;Choi, Hae Young;Yune, Tae Young
Neuropathic pain after spinal cord injury (SCI) is developed in about 80% of SCI patients and there is no efficient therapeutic drug to alleviate SCI-induced neuropathic pain. Here we examined the effect of estrogen on SCI-induced neuropathic pain at below-level and its effect on neuroinflammation as underlying mechanisms. Neuropathic pain is developed at late phase after SCI and a single dose of 17 beta-estradiol (100, 300 mu g/kg) were administered to rats with neuropathic pain after SCI through intravenous injection. As results, both mechanical allodynia and thermal hyperalgesia were significantly reduced by 17 beta-estradiol compared to vehicle control. Both microglia and astrocyte activation in the lamina I and II of L4-5 dorsal horn was also inhibited by 17 beta-estradiol. In addition, the levels of p-p38MAPK and p-ERK known to be activated in microglia and p-JNK known to be activated in astrocyte were significantly decreased by 17 beta-estradiol. Furthermore, the mRNA expression of inflammatory mediators such as Il-1 beta 6, Il-6, iNos, and Cox-2 was more attenuated in 17 beta-estradiol-treated group than in vehicle-treated group. Particularly, we found that the analgesic effect by 17 beta-estradiol was mediated via estrogen receptors, which are expressed in dorsal horn neurons. These results suggest that 17 beta-estradiol may attenuate SCI-induced neuropathic pain by inhibiting microglia and astrocyte activation followed inflammation.